NRS
NVO

Neville Rodie & Shaw’s Novo Nordisk NVO Stock Holding History

Neville Rodie & Shaw’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,000
Closed -$271K – 251
2022
Q4 		$271K Sell
4,000
-1,600
-29% -$93.8K 0.03% 222
2022
Q3 		$279K Hold
5,600
– – 0.03% 217
2022
Q2 		$312K Sell
5,600
-16,490
-75% -$915K 0.03% 215
2022
Q1 		$1.25M Hold
22,090
– – 0.09% 122
2021
Q4 		$1.24M Buy
+22,090
New +$1.2M 0.09% 128
2017
Q2 		– Sell
-24,700
Closed -$423K – 255
2017
Q1 		$423K Sell
24,700
-11,150
-31% -$194K 0.05% 184
2016
Q4 		$643K Sell
35,850
-3,600
-9% -$65.3K 0.08% 155
2016
Q3 		$820K Buy
39,450
+112
+0.3% +$2.78K 0.1% 141
2016
Q2 		$1.06M Sell
39,338
-1,126
-3% -$30.9K 0.13% 121
2016
Q1 		$1.1M Sell
40,464
-1,070
-3% -$28.7K 0.13% 121
2015
Q4 		$1.21M Sell
41,534
-890
-2% -$24.6K 0.15% 116
2015
Q3 		$1.15M Buy
42,424
+3,070
+8% +$86.9K 0.14% 123
2015
Q2 		$1.08M Sell
39,354
-530
-1% -$14.9K 0.12% 130
2015
Q1 		$1.06M Hold
39,884
– – 0.11% 138
2014
Q4 		$844K Sell
39,884
-120
-0.3% -$2.68K 0.09% 153
2014
Q3 		$952K Hold
40,004
– – 0.09% 143
2014
Q2 		$924K Buy
40,004
+8,604
+27% +$190K 0.09% 139
2014
Q1 		$716K Sell
31,400
-156,850
-83% -$3.34M 0.08% 137
2013
Q4 		$696K Buy
188,250
+150,600
+400% +$2.62M 0.08% 139
2013
Q3 		$638K Hold
37,650
– – 0.07% 141
2013
Q2 		$584K Buy
+37,650
New +$627K 0.07% 146

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Neville Rodie & Shaw's NVO Position: Q1 2023 in Review

Neville Rodie & Shaw sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 4,000 shares — an estimated $271K sold.

Neville Rodie & Shaw first reported a position in NVO in Q2 2013 and held it in 21 quarters. The position peaked at $1.25M in Q1 2022. 1,147 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • Neville Rodie & Shaw reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • Neville Rodie & Shaw sold 4,000 Novo Nordisk shares in Q1 2023, an estimated $271K.
  • Neville Rodie & Shaw first reported a position in Novo Nordisk in Q2 2013 and held it in 21 quarters.
  • Neville Rodie & Shaw's Novo Nordisk position peaked at $1.25M in Q1 2022.
  • 1,147 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on Neville Rodie & Shaw's 13F filing for Q1 2023, filed 4 Apr 2023.